Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Seborrhoeic Dermatitis of the Scalp
Interventions
DRUG

K40a

One tablespoon is to be applied to affected areas of the scalp once daily for 4 weeks. Thereafter, a maintenance phase of 4 weeks is to follow with application 3 times per week.

DRUG

K40b

One tablespoon is to be applied to affected areas of the scalp once daily for 4 weeks. Thereafter, a maintenance phase of 4 weeks is to follow with application 3 times per week.

DRUG

Placebo

One tablespoon is to be applied to affected areas of the scalp once daily for 4 weeks. Thereafter, a maintenance phase of 4 weeks is to follow with application 3 times per week.

Trial Locations (11)

Unknown

Dellenkliniken, Delsbo

Läkarhuset Farsta Centrum, Farsta

Stortorgets Hälsocentral, Gävle

Hedesunda Hälsocentral, Hedesunda

Familjehälsan, Hofors

Derbykliniken, Malmo

Möllevångens Läkargrupp,, Malmo

Möllevångens Läkargrupp, Malmo

Österpraktiken, Örebro

Department of Dermatology, Karolinska University Hospital, Stockholm

Hälsojouren, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Moberg Pharma AB

INDUSTRY